Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors

Abstract Background The peripheral blood eosinophil count prior to treatment has potential as a predictive biomarker for a beneficial clinical response to cancer immunotherapies. Therefore, the present study investigated the impact of the eosinophil count on overall survival (OS) in non‐small cell l...

Full description

Bibliographic Details
Main Authors: Eiji Takeuchi, Kensuke Kondo, Yoshio Okano, Seiya Ichihara, Michihiro Kunishige, Naoki Kadota, Hisanori Machida, Nobuo Hatakeyama, Keishi Naruse, Hirokazu Ogino, Hiroshi Nokihara, Tsutomu Shinohara, Yasuhiko Nishioka
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Thoracic Cancer
Subjects:
biomarker
immune checkpoint inhibitors
non‐small cell lung cancer
predictive factor
pretreatment eosinophils
Online Access:https://doi.org/10.1111/1759-7714.15100

Internet

https://doi.org/10.1111/1759-7714.15100

Similar Items